EPIB Exam #2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 1:23 AM on 4/8/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

22 Terms

1
New cards

Study Design:

A plan for data collection, analysis and interpretation

  • Descriptive

    • Exploratory investigations

    • Address who, what, where and whenĀ 

    • Describe occurrence of exposures and outcomesĀ 

    • Often generate hypothesesĀ 

  • Analytic studiesĀ 

    • Design is appropriate for testing a research questionĀ 

    • Address how and why

    • Assesses associations between exposures and outcomes

2
New cards

General Classification of Study Designs

  • ObservationalĀ 

    • Exposures occur in a ā€œnon-controlledā€ environment

    • Researchers observe and describe cases or relationships among variables

  • Experimental

    • Researchers have control over the exposure and who is exposed

  • Meta-analyses

    • Combines the results of several studies that address a set of related research hypotheses

3
New cards

Ecological Study Design

Observational approach that analyzes the relationship between exposure and outcome at the population or group level.

4
New cards

Ecological fallacy

Associations at the group level may not represent the exposure-outcome relationship at the individual level. Therefore, you cannot assume evidence of link between exposure and disease at the individual level

5
New cards

Ecological studies: advantages & disadvantages

  • Advantages

    • Quick, simple, inexpensive

    • Good approach for generating hypotheses when a disease has unknown etiology

  • Disadvantages

    • Ecological fallacy

    • Data is all at group level, not individuals

    • Imprecise measurement of exposure and disease

6
New cards

Correlation: Pearson’s r

  • Correlations can be measured using Pearson’s coefficients ā€œrā€

  • R can take on values range of -1 to +1

  • Smaller absolute values of r are weakerĀ 

  • Larger absolute values of r are stronger

  • Positive vs negative tells direction

7
New cards

Cross-Sectional Studies

Ā studies are a type of observational study design; investigator does not manipulate the exposure

  • Outcome and the exposures are measured simultaneously at a single time point

  • Provides a ā€œsnapshotā€ of a population

  • The unit of observation is the individualĀ 

  • Analysis is also focused on the individualĀ 

8
New cards

Advantages and disadvantages

  • AdvantagesĀ 

    • Relatively quick and inexpensiveĀ 

    • Good for measuring long-term exposures and immutable characteristicsĀ 

    • Can be generalizable if based on general populationĀ 

    • Multiple exposures and outcomes can be studied

  • DisadvantagesĀ 

    • Does not provide incidence dataĀ 

    • Not good for low prevalence or short-duration diseases

    • Cannot determine temporality of exposure and disease

    • Limited usefulness for inferring disease etiology

9
New cards

Measure of Association

  • Chance of something happening can be expressed as a risk and/or odds

  • Risk - chances of something happening / chances of all things happeningĀ 

  • Odds - chances of something happening / chances of it not happening

10
New cards

Defining Odds

  • Odds are the ratio of the probability of an event occurring to that of it not occurringĀ 

  • Odds - # of events of interest / # of events NOT of interestĀ 

  • Possible range is from 0-infinity (low to high odds)

11
New cards

Odds Ratio Interpretation

  • OR = 1 implies no associationĀ 

    • The odds of [exposure] among the [cases] is the same as odds of [exposure] among the [controls].ā€

  • OR < 1 pimples cases group has lower risk of exposureĀ 

    • Easiest to interpret as a percent: ā€œThe odds of [exposure] among the [cases] is [(1-OR)x100%] lower than among the [controls].ā€

  • OR < 1 = proactive factors

  • OR > 1 = risk factor

12
New cards

Cohort Studies

Observational study designs that describe a group of people selected based on a common characteristic

13
New cards

Prospective Cohort Study

Measure association between an exposure and risk of disease in the population, moving forward in time

14
New cards

Advantages and Disadvantages of Prospective Cohort Studies

  • AdvantagesĀ 

    • Collection on lots of exposuresĀ 

    • Ability to establish a temporal sequenceĀ 

    • Efficient for rare exposuresĀ 

  • DisadvantagesĀ 

    • Expensive

    • Time-consumingĀ 

    • Inefficient rare outcomesĀ 

    • Inefficient for diseases that take a long time to develop (with long induction and latency periods)

15
New cards

Retrospective Cohort Study

Measure association between an exposure and risk of disease in the population, moving backward in time

16
New cards

Retrospective Advantages

  • AdvantagesĀ 

    • Efficient for diseases with long latency periodsĀ 

    • Temporal sequence only when good historical records are used (not guaranteed with this study design)

    • Relative low-cost, quick to accomplish only when historical records are used

17
New cards

Risks

Absolute risk for exposed groups: A / (A+B)

  • Absolute risk for unexposed groups: C / (C+D)

  • Risk difference: (A / (A+B)) - (C / (C+D))

  • Relative risk: A / (A+B) / C / (C+D)

  • InterpretationsĀ 

    • Relative risk

      • [Exposed group] had [RR value] times the risk of [outcome] compared to the [unexposed group]

    • Risk difference

      • [Exposed group] had [RD value] more/fewer cases of [outcome] per [rate base] compared to [the unexposed group]

18
New cards

Experimental Studies

  • Manipulations of variables → assigning to exposure group

  • Only use when feasible and ethical

  • Types: quasi-experimental and randomized control trial

19
New cards

Phases of Clinical Trials

  • Phase 1 - tests for safety on healthy individual

  • Phase 2 - tests for side effects on a larger group

  • Phase 3 - tests for long term effectiveness and a wider demographicĀ 

  • FDA approval - safe for public use

  • Phase 4 - can be take off market and continues to test for effectiveness

20
New cards

Measures of Association

  • Relative risk

  • RR = 1, no associationĀ 

  • RR>1, treatment group more likely to develop the outcomeĀ 

  • RR<1, treatment group less likely to develop

21
New cards

Strengths of experimental designs

  • Provides the strongest evidence of associationĀ 

  • Manipulation means having controlĀ 

    • Amount of exposureĀ 

    • Timing and frequence

    • Period of observation

22
New cards

Limitations of experimental designs

  • Artificial settingĀ 

  • Expensive

  • Ethical concerns